{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:40:24Z","timestamp":1773002424393,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.bbr.2009.08.010","type":"journal-article","created":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T05:34:51Z","timestamp":1250228091000},"page":"511-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Involvement of the serotonergic system in the anxiolytic-like effect caused by m-trifluoromethyl-diphenyl diselenide in mice"],"prefix":"10.1016","volume":"205","author":[{"given":"C\u00e9sar Augusto","family":"Br\u00fcning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Prigol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliano A.","family":"Roehrs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Wayne","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilson","family":"Zeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2009.08.010_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0163-7258(00)00083-8","article-title":"The psychobiology of anxiolytic drug. Part 2: pharmacological treatments of anxiety","volume":"3","author":"Argyropoulos","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bbr.2009.08.010_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02245179","article-title":"The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models","volume":"117","author":"Artaiz","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2009.08.010_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/1028415021000055925","article-title":"Selenium intake, mood and other aspects of psychological functioning","volume":"5","author":"Benton","year":"2001","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.bbr.2009.08.010_bib4","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/0006-3223(91)90251-G","article-title":"The impact of selenium supplementation on mood","volume":"29","author":"Benton","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.08.010_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/phrs.1993.1015","article-title":"The effect of DAU 6215, a novel 5-HT3 antagonist, in animal models of anxiety","volume":"27","author":"Borsini","year":"1993","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bbr.2009.08.010_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein\u2013dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bbr.2009.08.010_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/syn.890010511","article-title":"Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain","volume":"1","author":"Blier","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2009.08.010_bib8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0091-3057(89)90033-6","article-title":"Exploration of mice in a black and white box: validation as a model of anxiety","volume":"32","author":"Costall","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2009.08.010_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2005.07.018","article-title":"Light\/dark cycle manipulation influences mice behavior in the elevated plus maze","volume":"166","author":"Cl\u00e9net","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2009.08.010_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behavior for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2009.08.010_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0091-3057(01)00485-3","article-title":"The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism","volume":"68","author":"Eguchi","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2009.08.010_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF00442817","article-title":"Lack of effects of 5-HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat","volume":"99","author":"File","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2009.08.010_bib13","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.pnpbp.2008.05.008","article-title":"Diphenyl diselenide exerts anxiolytic-like effect in Wistar rats: Putative roles of GABAA and 5HT receptors","volume":"32","author":"Ghisleni","year":"2008","journal-title":"Prog Neuro-psychoph"},{"key":"10.1016\/j.bbr.2009.08.010_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jep.2008.08.012","article-title":"Central effects of isolated fractions from the root of Petiveria alliacea L. (tipi) in mice","volume":"120","author":"Gomes","year":"2008","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bbr.2009.08.010_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.bbr.2009.08.010_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.08.010_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0028-3908(89)90188-3","article-title":"Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice","volume":"28","author":"Kilfoil","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2009.08.010_bib18","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/0006-2952(65)90025-0","article-title":"A rapid microfluorimetric determination of monoamine oxidase","volume":"14","author":"Krajl","year":"1965","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbr.2009.08.010_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.phrs.2008.11.006","article-title":"Brain and lungs of rats are differently affected by cigarette smoke exposure: Antioxidant effect of an organoselenium compound","volume":"59","author":"Luchese","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bbr.2009.08.010_bib20","first-page":"291","article-title":"Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test","volume":"188","author":"Masse","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2009.08.010_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neulet.2006.09.079","article-title":"An organic selenium compound attenuates apomorphine-induced stereotypy in mice","volume":"410","author":"Machado","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2009.08.010_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mrgentox.2009.01.003","article-title":"3,3-Ditrifluoromethyldiphenyl diselenide: A new organoselenium compound with interesting antigenotoxic and antimutagenic activities","volume":"673","author":"Machado","year":"2009","journal-title":"Mutat Res"},{"key":"10.1016\/j.bbr.2009.08.010_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0003-2697(84)90780-2","article-title":"3-(p-Hydroxyphenyl)propionic acid as a new fluorogenic reagent for amine oxidase assays","volume":"138","author":"Matsumoto","year":"1984","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bbr.2009.08.010_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0300-483X(02)00423-7","article-title":"Investigations into the potential neurotoxicity induced by diselenides in mice and rats","volume":"183","author":"Nogueira","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.bbr.2009.08.010_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/cr0406559","article-title":"Organoselenium and organotellurium compounds: toxicology and pharmacology","volume":"104","author":"Nogueira","year":"2004","journal-title":"Chem Rev"},{"issue":"Suppl 2","key":"10.1016\/j.bbr.2009.08.010_bib26","first-page":"S69","article-title":"Reversible monoamine oxidase-A inhibitors in resistant major depression","volume":"16","author":"Nolen","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.bbr.2009.08.010_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-977X(99)00065-6","article-title":"5-HT3 receptor antagonists and anxiety; a preclinical and clinical review","volume":"10","author":"Olivier","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2009.08.010_bib28","series-title":"Selenium reagents and intermediates in organic synthesis","first-page":"25","article-title":"Selenoorganic functional groups","author":"Paulmier","year":"1986"},{"key":"10.1016\/j.bbr.2009.08.010_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.bbr.2009.08.010_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cbi.2008.07.006","article-title":"Protective effect of unsymmetrical dichalcogenide, a novel antioxidant agent, in vitro and an in vivo model of brain oxidative damage","volume":"176","author":"Prigol","year":"2008","journal-title":"Chem-Biol Interact"},{"key":"10.1016\/j.bbr.2009.08.010_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cbf.1559","article-title":"Antioxidant effect of diphenyl diselenide on oxidative stress caused by acute physical exercise in skeletal muscle and lungs of mice","volume":"27","author":"Prigol","year":"2009","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.bbr.2009.08.010_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bej.2009.02.015","article-title":"Protective Effect of Disubstituted Diaryl Diselenides on Cerebral Oxidative Damage Caused by Sodium Nitroprusside","volume":"45","author":"Prigol","year":"2009","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.bbr.2009.08.010_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.toxlet.2009.04.026","article-title":"Convulsant effect of diphenyl diselenide in rats and mice and its relationship to plasma levels","volume":"189","author":"Prigol","year":"2009","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bbr.2009.08.010_bib34","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/jm950543x","article-title":"Novel Selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines","volume":"39","author":"Rault","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.bbr.2009.08.010_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(00)02490-9","article-title":"The importance of selenium to human health","volume":"356","author":"Rayman","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2009.08.010_bib36","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1590\/S0100-879X2006005000171","article-title":"Pharmacology and toxicology of diphenyl diselenide in several biological models","volume":"40","author":"Rosa","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.bbr.2009.08.010_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2006.10.003","article-title":"Antinociceptive properties of diphenyl diselenide: evidences for the mechanism of action","volume":"555","author":"Savegnago","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2009.08.010_bib38","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.pbb.2007.09.015","article-title":"Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: Involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action","volume":"88","author":"Savegnago","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2009.08.010_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.etap.2008.11.007","article-title":"Structural modifications into diphenyl diselenide molecule do not cause toxicity in mice","volume":"27","author":"Savegnago","year":"2009","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.bbr.2009.08.010_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0091-3057(01)00660-8","article-title":"Anxiogenic activity of Myristica fragrans seeds","volume":"71","author":"Sonavane","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2009.08.010_bib41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbr.2008.08.027","article-title":"Stimulation of 5-HT1A or 5-HT2A receptors in the ventrolateral periaqueductal gray causes anxiolytic-, but not panicolytic-like effect in rats","volume":"197","author":"Soares","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2009.08.010_bib42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0024-3205(01)01178-X","article-title":"Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals: potential implications in relation to oxidative stress","volume":"69","author":"Soto-Otero","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2009.08.010_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/syn.890010103","article-title":"Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists","volume":"1","author":"Sprouse","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2009.08.010_bib44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0009-3084(87)90053-3","article-title":"The role of selenium peroxidases in the protection against oxidative damage of membranes","volume":"44","author":"Ursini","year":"1987","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.bbr.2009.08.010_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02246976","article-title":"Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze","volume":"110","author":"Vasar","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2009.08.010_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.reprotox.2006.09.008","article-title":"Repeated administration of diphenyl diselenide to pregnant rats induces adverse effects on embryonic\/fetal development","volume":"23","author":"Weis","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.bbr.2009.08.010_bib47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat Ver Neurosci"},{"key":"10.1016\/j.bbr.2009.08.010_bib48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol Bull"},{"key":"10.1016\/j.bbr.2009.08.010_bib49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0161-813X(03)00097-4","article-title":"Clinical pharmacology of MAO inhibitors: safety and future","volume":"25","author":"Yamada","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbr.2009.08.010_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.2000.tb10947.x","article-title":"Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors","volume":"403","author":"Zohar","year":"2000","journal-title":"Acta Psychiatr Scand Suppl"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432809004781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432809004781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:57:01Z","timestamp":1759064221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432809004781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0166432809004781"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2009.08.010","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of the serotonergic system in the anxiolytic-like effect caused by m-trifluoromethyl-diphenyl diselenide in mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2009.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}